Dermafrac™: An Innovative New Treatment for Periorbital Melanosis in a Dark-Skinned Male Patient

Periorbital melanosis (under eye dark circles) is an often idiopathic cosmetically disturbing condition that is poorly responsive to currently available treatment modalities. We present the case of a 48-year-old man (skin phototype V) with significant idiopathic periorbital melanosis and who had goo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahni, Kanika, Kassir, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800292/
https://www.ncbi.nlm.nih.gov/pubmed/24163534
http://dx.doi.org/10.4103/0974-2077.118420
_version_ 1782287950713716736
author Sahni, Kanika
Kassir, Martin
author_facet Sahni, Kanika
Kassir, Martin
author_sort Sahni, Kanika
collection PubMed
description Periorbital melanosis (under eye dark circles) is an often idiopathic cosmetically disturbing condition that is poorly responsive to currently available treatment modalities. We present the case of a 48-year-old man (skin phototype V) with significant idiopathic periorbital melanosis and who had good to excellent reduction in periorbital melanosis with the new DermaFrac™, which combines microneedling with simultaneous infusion of a serum containing active ingredients. The possible mechanisms of benefit are discussed. DermaFrac™ may be an innovative and effective new treatment option for patients with periorbital melanosis.
format Online
Article
Text
id pubmed-3800292
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-38002922013-10-25 Dermafrac™: An Innovative New Treatment for Periorbital Melanosis in a Dark-Skinned Male Patient Sahni, Kanika Kassir, Martin J Cutan Aesthet Surg Case Report Periorbital melanosis (under eye dark circles) is an often idiopathic cosmetically disturbing condition that is poorly responsive to currently available treatment modalities. We present the case of a 48-year-old man (skin phototype V) with significant idiopathic periorbital melanosis and who had good to excellent reduction in periorbital melanosis with the new DermaFrac™, which combines microneedling with simultaneous infusion of a serum containing active ingredients. The possible mechanisms of benefit are discussed. DermaFrac™ may be an innovative and effective new treatment option for patients with periorbital melanosis. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3800292/ /pubmed/24163534 http://dx.doi.org/10.4103/0974-2077.118420 Text en Copyright: © Journal of Cutaneous and Aesthetic Surgery http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Sahni, Kanika
Kassir, Martin
Dermafrac™: An Innovative New Treatment for Periorbital Melanosis in a Dark-Skinned Male Patient
title Dermafrac™: An Innovative New Treatment for Periorbital Melanosis in a Dark-Skinned Male Patient
title_full Dermafrac™: An Innovative New Treatment for Periorbital Melanosis in a Dark-Skinned Male Patient
title_fullStr Dermafrac™: An Innovative New Treatment for Periorbital Melanosis in a Dark-Skinned Male Patient
title_full_unstemmed Dermafrac™: An Innovative New Treatment for Periorbital Melanosis in a Dark-Skinned Male Patient
title_short Dermafrac™: An Innovative New Treatment for Periorbital Melanosis in a Dark-Skinned Male Patient
title_sort dermafrac™: an innovative new treatment for periorbital melanosis in a dark-skinned male patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800292/
https://www.ncbi.nlm.nih.gov/pubmed/24163534
http://dx.doi.org/10.4103/0974-2077.118420
work_keys_str_mv AT sahnikanika dermafracaninnovativenewtreatmentforperiorbitalmelanosisinadarkskinnedmalepatient
AT kassirmartin dermafracaninnovativenewtreatmentforperiorbitalmelanosisinadarkskinnedmalepatient

Ejemplares similares